Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
92,618,112
-
Share change
-
-1,331,958
-
Total reported value
-
$10,675,977,715
-
Put/Call ratio
-
93%
-
Price per share
-
$115.22
-
Number of holders
-
567
-
Value change
-
-$220,711,285
-
Number of buys
-
292
-
Number of sells
-
282
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2024
As of 30 Sep 2024 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 567 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 92,618,112 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Bellevue Group AG, GEODE CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and JPMORGAN CHASE & CO.
This table shows 570 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.